Phenotypic analysis of KIR expression on CD56+ cells of HLA-matched donors used as effector cells inFigure 3C-D
. | . | . | % CD56+ . | . | . | ||
|---|---|---|---|---|---|---|---|
| Donor . | HLA-Cw . | HLA-C group . | KIR2DL1 . | KIR2DL2 . | KIR2DL2/KIR2DL1 ratio . | ||
| Patient 4 | 03/07 | 1/1 | 7 | 10 | 1.4 | ||
| Patient 5 | 04/15 | 2/2 | 8 | 4.5 | 0.6 | ||
. | . | . | % CD56+ . | . | . | ||
|---|---|---|---|---|---|---|---|
| Donor . | HLA-Cw . | HLA-C group . | KIR2DL1 . | KIR2DL2 . | KIR2DL2/KIR2DL1 ratio . | ||
| Patient 4 | 03/07 | 1/1 | 7 | 10 | 1.4 | ||
| Patient 5 | 04/15 | 2/2 | 8 | 4.5 | 0.6 | ||